510(k) Report

510(k) · Cleared

Cleared

Pro HMPV+ Assay

K082688510(k) TraditionalCleared Nov 7, 200853-day reviewClass II21 CFR 866.3980

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Prodesse, Inc. · OEM Human Metapneumovirus (Hmpv) Rna Assay System

Cleared on Nov 7, 2008 as substantially equivalent to DEN070013 (Luminex Molecular Diagnostics, Inc., 2008) after a 53-day review. Its family tree reaches back 1 generation to 2008. 15 later devices descend from it.

Decided
Nov 7, 2008
Review
53 days
Class
Class II
Product code
OEM
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN070013 (2008). 15 later devices descend from it, 5 citing it directly.

Descendants, by year cleared 2013: 4 descendants cleared2011: 1 descendant cleared2009: 3 descendants cleared2016: 1 descendant cleared2017: 1 descendant cleared2023: 1 descendant cleared2018: 1 descendant cleared2019: 2 descendants cleared2026: 1 descendant clearedDEN070013 · ID-Tag Respiratory Viral Panel · Luminex Molecular Diagnostics, Inc. · 200820052010201520202025
Descendants, by generation 1 generation forward: 5 descendants2 generations forward: 6 descendants3 generations forward: 1 descendant4 generations forward: 2 descendants5 generations forward: 1 descendant DEN070013 · ID-Tag Respiratory Viral Panel · Luminex Molecular Diagnostics, Inc. · 20080+5
  1. Root · 1 generation backDEN070013 ID-Tag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc. · 2008
  2. This deviceK082688 Pro HMPV+ AssayProdesse, Inc. · 2008
  3. Descendant · cites it directly · 7 of its ownK131813 Quidel Molecular RSV + HMPV AssayQuidel Corp. · 2013
  4. Descendant · 2 generations on · 4 of its ownK161375 Alere i RSV, Alere i Instrument, Alere i RSV Control Swab KitAlere Scarborough, Inc. · 2016 · Recalled
  5. Descendant · 3 generations on · 3 of its ownK173932 Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i…Alere Scarborough, Inc. · 2018
  6. Descendant · cites it directly · 2 of its ownK112490 Quidel Molecular HMPV AssayQuidel Corp. · 2011
  7. Descendant · cites it directly · 2 of its ownK090073 D3 Dfa Metapneumovirus Identification KitDiagnostic Hybrids, Inc. · 2009

Showing 5 of 15 descendants. See all descendants

Descendants cleared per year

2009: 32011: 12013: 42016: 12017: 12018: 12019: 22023: 12026: 1
2009high 4 (2013) · low 0 (2010)2026

Most influential descendants

Showing 5 of 15 · See all
  • K131813Quidel Molecular RSV + HMPV AssayQuidel Corp. · 2013 · cites it directly7descendants
  • K161375Alere i RSV, Alere i Instrument, Alere i RSV Control Swab KitAlere Scarborough, Inc. · 2016 · 2 generations on4descendants
  • K173932Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2Alere Scarborough, Inc. · 2018 · 3 generations on3descendants
  • K112490Quidel Molecular HMPV AssayQuidel Corp. · 2011 · cites it directly2descendants
  • K090073D3 Dfa Metapneumovirus Identification KitDiagnostic Hybrids, Inc. · 2009 · cites it directly2descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN070013ID-Tag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc.2008—
0 (this device)K082688Pro HMPV+ AssayProdesse, Inc.2008—
+1K131813Quidel Molecular RSV + HMPV AssayQuidel Corp.2013—
+2K161375Alere i RSV, Alere i Instrument, Alere i RSV Control Swab KitAlere Scarborough, Inc.20162
+3K173932Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2Alere Scarborough, Inc.2018—
+1K112490Quidel Molecular HMPV AssayQuidel Corp.2011—
+1K090073D3 Dfa Metapneumovirus Identification KitDiagnostic Hybrids, Inc.2009—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200930
201110
201340
201610
201710
201810
201920
202310
202610
FIG. 1 — Lineage of K082688, 2008–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OEM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OEM device

  1. #1 K230349 Lyra RSV+hMPV Assayscore 6.2 · 5 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN070013ID-Tag Respiratory Viral Panel
Our reading of the summary gave K063765, which is not in FDA’s 510(k) list. The device the summary names is FDA’s De Novo DEN070013, ID-Tag Respiratory Viral Panel (Luminex Molecular Diagnostics, Inc.), granted Jan 3, 2008; older De Novo requests were first filed under a 510(k) number, so this links to the grant.
Luminex Molecular Diagnostics, Inc.2008—

Also cleared against DEN070013: 11 other devices →

What descends from it? (15)

See all 15

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K131813Quidel Molecular RSV + HMPV AssayQuidel Corp.20137
K112490Quidel Molecular HMPV AssayQuidel Corp.20112
K090073D3 Dfa Metapneumovirus Identification KitDiagnostic Hybrids, Inc.20092
K123838Pro HMPV+ AssayGen-Probe Prodesse, Inc.20131
K122189Quidel Molecular RSV + HMPV AssayQuidel Corp.20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K131813 (Quidel Corp., 2013) has gone furthest, with 7 descendants of its own.
  • 11 other devices also cite its predicate DEN070013.

How does its category compare?

All OEM devices

OEM Human Metapneumovirus (Hmpv) Rna Assay System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · OEM

1in 2023

2008: 12011: 12013: 32023: 1
2007high 3 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OEM

34in 2013

2013: 34 days median
2007high 34 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OEM

No recall names OEM since 2007.

Adverse event reports per year · OEM

1in 2023

2019: 12023: 1
2007high 1 (2019) · low 0 (2007)2025

MAUDE reports naming product code OEM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20081—00
20090—00
20100—00
20111—00
20120—00
201333400
20140—00
20150—00
20160—00
20170—00
20180—00
20190—01
20200—00
20210—00
20220—00
20231—01
20240—00
20250—00
20260—0—

What is it indicated for?

The Pro hMPV+ Assay is a Real Time RT-PCR in vitro diagnostic test for the qualitative detection of human Metapneumovirus (hMPV) nucleic acid isolated and purified from nasopharyngeal swab (NP) specimens obtained from individuals exhibiting signs and symptoms of acute respiratory infection. This assay targets a highly conserved region of the Nucleocapsid gene of hMPV. The detection of hMPV nucleic acid from symptomatic patients aids in the diagnosis of…

Read the full statement (119 words)

The Pro hMPV+ Assay is a Real Time RT-PCR in vitro diagnostic test for the qualitative detection of human Metapneumovirus (hMPV) nucleic acid isolated and purified from nasopharyngeal swab (NP) specimens obtained from individuals exhibiting signs and symptoms of acute respiratory infection. This assay targets a highly conserved region of the Nucleocapsid gene of hMPV. The detection of hMPV nucleic acid from symptomatic patients aids in the diagnosis of human respiratory hMPV infection if used in conjunction with other clinical and laboratory findings. This test is not intended to differentiate the four genetic sub-lineages of hMPV.

Negative results do not preclude hMPV infection and should not be used as the sole basis for diagnosis, treatment or other management decisions.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082688: Pro HMPV+ Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K082688

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026